In this study, high expression of CHD1L was detected in NSCLC patients tissues and the overexpressed of CHD1L was associated with poorer survival rates in NSCLC patients who were treated with cisplatin-based chemotherapy. Here, CHD1L is linked to non-small cell lung carcinoma.